Contact

Our portfolio

SigmaScreening

SigmaScreening has developed a mammography device that reduces pain and improves diagnostic accuracy. Founded by Amsterdam UMC professors, the company aims to enhance breast cancer detection with their patented technology. SigmaScreening has licensed their technology to Teledyne, who continue development of the device.

  • Institute: Amsterdam UMC
Industry: Imaging, Medical Technology, Oncology
  • Founding year: 2010

Want to get in contact about SigmaScreening?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Quantib
Enhancing patient care with AI-driven radiology solutions for clinical practice.
Kling Biotherapeutics
Discovering novel antibodies for cancer and infectious disease treatments.
Haermonics
Preventing post-surgical complications with the PURE pericardial flushing device.
Inreda Diabetic
Improving diabetes management with the AP, a closed-loop bi-hormonal artificial pancreas.
Quantib
Enhancing patient care with AI-driven radiology solutions for clinical practice.
Kling Biotherapeutics
Discovering novel antibodies for cancer and infectious disease treatments.
Haermonics
Preventing post-surgical complications with the PURE pericardial flushing device.
Inreda Diabetic
Improving diabetes management with the AP, a closed-loop bi-hormonal artificial pancreas.
Explore full AAV portfolio
Contact